Hap Trading, LLC Adaptimmune Therapeutics PLC Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Adaptimmune Therapeutics PLC stock. As of the latest transaction made, Hap Trading, LLC holds 15,100 shares of ADAP stock, worth $8,909. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,100Holding current value
$8,909% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ADAP
# of Institutions
83Shares Held
145MCall Options Held
60.8KPut Options Held
5.8K-
Matrix Capital Management Company, LP Waltham, MA37.7MShares$22.2 Million1.71% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA27.4MShares$16.2 Million1.13% of portfolio
-
Nea Management Company, LLC Timonium, MD17.1MShares$10.1 Million1.24% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR13.3MShares$7.85 Million0.46% of portfolio
-
Baillie Gifford & CO11.8MShares$6.97 Million0.01% of portfolio
About Adaptimmune Therapeutics PLC
- Ticker ADAP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 163,370,000
- Market Cap $96.4M
- Description
- Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...